MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1164/rccm.201712-2452oc

Медицинская библиотека · American journal of respiratory and critical care medicine · 2018

A Multivariable Prediction Model for Pneumocystis jirovecii Pneumonia in Hematology Patients with Acute Respiratory Failure.

Azoulay Elie, Roux Antoine, Vincent François, Kouatchet Achille, Argaud Laurent, Rabbat Antoine, Mayaux Julien, Perez Pierre, Pène Frédéric, Nyunga Martine, Bruneel Fabrice, Klouche Kada, Mokart Djamel, Darmon Michael, Chevret Sylvie, Lemiale Virginie

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

RATIONALE: The incidence of Pneumocystis jirovecii pneumonia (PjP) is rising. Longer time to treatment is associated with higher mortality.

OBJECTIVES

To develop a multivariable risk prediction model for PjP diagnosis.

METHODS

In a prospective multicenter cohort of ICU patients with hematological malignancies and acute respiratory failure, factors associated with documented PjP were identified. The risk prediction model was tested in an independent prospective multicenter cohort. We assessed discrimination (by areas under the receiver operating characteristic curves [AUCs]) and goodness of fit (by Hosmer-Lemeshow statistics). Model performance was assessed using 30 sets of imputed data sets.

MEASUREMENTS AND MAIN

RESULTS

Among the 1,330 patients, 134 of 1,092 (12.3%; 95% confidence interval [CI], 10.4-14.4%) had proven PjP in the derivation cohort, as did 15 of 238 (6.3%, 95% CI, 3.6-10.2%) in the validation cohort. The model included age, lymphoproliferative disease, anti-Pneumocystis prophylaxis, the number of days between respiratory symptom onset and ICU admission, shock, chest radiograph pattern, and pleural effusion. The median (interquartile range) score was 3.5 (1.5-5.0) (range, -3.5 to 8.5) in the derivation cohort and 1.0 (0-2.0) (range, -3.5 to 6.0) in the validation cohort. The best threshold was defined on the validation sample as 3, allowing us to reach 86.7% sensitivity and 67.7% specificity for PjP, with a negative predictive value of 97.9% in the case of 10% prevalence. The score had good calibration (goodness of fit, -0.75) and discrimination in the derivation cohort (mean AUC, 0.80; 95% CI, 0.76-0.84) and validation cohort (mean AUC, 0.83; 95% CI, 0.72-0.93).

CONCLUSIONS

The PjP score for hematology patients with acute respiratory failure can be computed at admission, based on readily available variables. Potential clinical benefits of using this score deserve assessment.

Для цитирования: Azoulay Elie, Roux Antoine, Vincent François, Kouatchet Achille, Argaud Laurent, Rabbat Antoine, Mayaux Julien, Perez Pierre, Pène Frédéric, Nyunga Martine, Bruneel Fabrice, Klouche Kada, Mokart Djamel, Darmon Michael, Chevret Sylvie, Lemiale Virginie. A Multivariable Prediction Model for Pneumocystis jirovecii Pneumonia in Hematology Patients with Acute Respiratory Failure.. American journal of respiratory and critical care medicine. 2018. DOI: 10.1164/rccm.201712-2452oc.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.